Antecip Bioventures II LLC
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
0
Ending by 2030
May 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Jan 2 to 16, 2027 · next Jan 2
- 2 fees due Feb 8 to 22, 2027 · next Feb 8
- 5 fees due Mar 8 to 24, 2027 · next Mar 8
- 3 fees due Apr 6 to 27, 2027 · next Apr 6
- 2 fees due May 5, 2027
- 10 fees due Jun 1 to 24, 2027 · next Jun 1
- 2 fees due Jul 19 to 30, 2027 · next Jul 19
- 3 fees due Aug 4 to 23, 2027 · next Aug 4
- 9 fees due Sep 8 to 24, 2027 · next Sep 8
- 3 fees due Oct 5 to 30, 2027 · next Oct 5
Recent changes
- 5 of the patents on this record were granted since Aug 23, 2026
- Nov 17 US 12,797,383 Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
- Nov 3 US 12,778,946 Bupropion Dosage Forms with Reduced Food and Alcohol Dosing Effects
- Nov 3 US 12,778,911 Compounds and Combinations Thereof for Treating Neurological and Psychiatric Conditions
- Oct 20 US 12,766,139 Bupropion as a Modulator of Drug Activity
- Sep 22 US 12,740,949 Treatment of Agitation Associated with Alzheimer's Disease with a Combination of Bupropion and Dextromethorphan
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,861,648 | Osteoclast Inhibitors for Knee Conditions In force · Medium confidence | In force | Medium confidence | |
| US 9,895,383 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome In force · Medium confidence | In force | Medium confidence | |
| US 9,901,589 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome In force · Medium confidence | In force | Medium confidence | |
| US 10,016,445 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome In force · Medium confidence | In force | Medium confidence | |
| US 10,016,446 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Paget's Disease of Bone In force · Medium confidence | In force | Medium confidence | |
| US 10,028,908 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome In force · Medium confidence | In force | Medium confidence | |
| US 10,028,969 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome In force · Medium confidence | In force | Medium confidence | |
| US 10,034,890 | Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome In force · Medium confidence | In force | Medium confidence | |
| US 10,092,581 | Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment In force · Medium confidence | In force | Medium confidence | |
| US 10,111,837 | Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 277: 2 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
18 pending · 108 abandoned